A consortium comprised of funds advised by Apax Partners, together with controlled affiliates of Canada Pension Plan Investment Board (CPSP Investments), has completed its acquisition of Kinetic Concepts, Inc (NYSE: KCI) for USD68.50 per common share in cash. KCI shareholders approved the transaction at a special meeting held on 28 October.
KCI is a US-based medical device company focused on the design, manufacture, marketing and service of therapies and products for the wound care, tissue regeneration and therapeutic support system markets. The transaction is valued at approximately USD6.1 billion, including KCI’s outstanding debt.
The consortium plans to work actively in partnership with the management of KCI to further invest in the global medical products sector to expand the company’s core business, develop innovative products and extend into new geographies where significant opportunities exist.
Morgan Stanley & Co. LLC acted as financial advisor to the consortium. Debt financing was secured from Morgan Stanley & Co. LLC, BofA Merrill Lynch and Credit Suisse AG. Simpson Thacher & Bartlett LLP acted as legal advisor to the consortium. Kirkland & Ellis LLP acted as legal advisor on the financing to the consortium. Epstein Becker Green acted as healthcare regulatory counsel to the consortium. CPPIB was also separately advised by Torys LLP. PSP Investments was also separately advised by Weil, Gotshal & Manges LLP.
